A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #213

Stimulation of growth hormone secretion from seabream pituitary cells in primary culture by growth hormone secretagogues is independent of growth hormone transcription.

Chan CB, Fung CK, Fung W, et al. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP. 2004.
Weak / noneIn vitroMentions: Ipamorelin

Editor's note

A comparative-endocrinology, in-vitro study in fish pituitary cells, where ipamorelin serves as one of several tool compounds probing how growth-hormone secretagogues work — not a study of ipamorelin as a therapy. Using cultured black-seabream pituitary cells, the researchers showed that several secretagogues, including ipamorelin and GHRP-2, dose-dependently stimulated growth-hormone release (with EC50s in the nanomolar range), while human ghrelin did not. Crucially, the increased GH release was not matched by increased GH gene transcription, even after 48 hours — differing from earlier rat findings and implying the peptides act on secretion of pre-formed hormone rather than on its synthesis. This is a clean mechanistic result, but in fish cells in a dish. For human readers it is contextual only: it reinforces that ipamorelin acts as a GH secretagogue via a conserved receptor. It carries no implication for human efficacy, safety, or dosing; these are preclinical, non-mammalian, in-vitro findings.

Plain-language abstract

This laboratory study looked at how growth-hormone-releasing compounds make pituitary cells secrete growth hormone, using cells from the black seabream fish grown in culture. The researchers tested several compounds, including ipamorelin, GHRP-2, human ghrelin, and two non-peptide substances, and measured both the growth hormone the cells released and the activity of the growth-hormone gene inside them. All the compounds except human ghrelin triggered growth-hormone release in a dose-dependent way, effective at very low (nanomolar) concentrations. Notably, even though these compounds boosted the amount of growth hormone released, they did not increase activity of the growth-hormone gene — even after up to 48 hours. This suggests the peptides prompt the cells to release hormone they have already made, rather than to produce more, which differs from what had been reported earlier in rats. Because this was done in fish cells in a dish, it explains a mechanism but says nothing about whether ipamorelin benefits or harms people; human studies would be needed for any such conclusion.